SEC 13F Intelligence

Propel Bio Management, LLC / APLT

Propel Bio Management, LLC’s Applied Therapeutics Inc Position

Does Propel Bio Management, LLC own Applied Therapeutics Inc (APLT)? Not currently — the last reported position was 11.29M shares worth $7M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$7M
Q3 2025
Shares
11.29M
% of Portfolio
+6.83%
Quarters Held
8
position exited

Position History APLT

Reported value by quarter
Q4 ’23: $18MQ4 ’23Q1 ’24: $42MQ1 ’24Q2 ’24: $31MQ2 ’24Q3 ’24: $56MQ3 ’24Q4 ’24: $8MQ4 ’24Q1 ’25: $6MQ1 ’25Q2 ’25: $4MQ2 ’25Q3 ’25: $7MQ3 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202511.29M$7M+6.83%
Q2 202511.29M$4M+4.26%
Q1 202511.29M$6M+6.41%
Q4 20249.62M$8M+8.18%
Q3 20246.57M$56M+32.38%
Q2 20246.57M$31M+19.89%
Q1 20246.11M$42M+24.19%
Q4 20235.37M$18M+14.93%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Propel Bio Management, LLC’s full portfolio or all institutional holders of APLT.